Immunoassay Markets Strategies And Trends. Forecasts By Instrument Type And By Application And By Country. With Multiplex And Point Of Care Market Analysis, Executive Guides And Including Customized Forecasting And Analysis. 2019 To 2023.

  • ID: 4491324
  • Report
  • Region: Global
  • 232 Pages
  • Howe Sound Research
1 of 5

FEATURED COMPANIES

  • Abbott Diagnostics
  • BioCartis
  • Diasorin S.p.A.
  • Hycor Biomedical
  • Molecular Devices
  • Randox Toxicology
  • MORE

The workhorse of the diagnostic industry is finding new legs.  Advances in genetic knowledge are creating new markets for immunoassay. Rapid diagnostics, point of care, biomarkers and consumer markets are all areas of expansion while traditional immunoassay maintains a strong position in the growing market for clinical diagnostics. We profile 44 companies, large and small, working in this area.

Our research makes you the expert in your organization. Get our research team working for you by ordering all, or a portion, of this comprehensive report.  Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges.

All report data is available in Excel format on request.

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Diagnostics
  • BioCartis
  • Diasorin S.p.A.
  • Hycor Biomedical
  • Molecular Devices
  • Randox Toxicology
  • MORE

1. Introduction and Market Definition
1.1 Immunoassay Markets Definition In This Report
1.1.1 Enzyme Based
1.1.2 Chemiluminescence
1.1.3 Immunofluorescence
1.1.4 Radioimmunoassay
1.1.5 NAT & Other
1.1.6 Reagents and Kits
1.1.7 Infectious Disease
1.1.8 Auto Immune
1.1.9 Endocrinology
1.1.10 Oncology
1.1.11 Cardiology
1.1.12 Other Specialty
1.2 Market Definition
1.2.1 Revenue Market Size
1.3 U.S. Medical Market and laboratory Testing - Perspective
1.3.1 U.S. Medicare Expenditures for laboratory testing

2. Market Overview
2.1 Market Participants Play Different Roles
2.1.1 Instrument Manufacturer/IVD Vendor
2.1.2 Independent lab specialized/esoteric
2.1.3 Independent lab national/regional
2.1.4 Independent lab analytical
2.1.5 Public National/regional lab
2.1.6 Hospital lab
2.1.7 Physician lab
2.1.8 Audit body
2.2 Immunoassay –Markets and Discussion
2.2.1 Instruments – Genetics changes the picture
2.2.1.1 RIA – A Technology Shows its Age
2.2.1.2 Immunoassay vs. Sequencing – A See Saw Battle
2.2.1.3 The Shrinking Instrument
2.2.1.4 Research Funding and Capital Expense – Instrument Pooling
2.2.1.4 Multiplex vs. POC – A Tradeoff Analysis
2.2.2 Reagents and Kits – Genetics changes the picture
2.2.1.1 Bigger Test Menus a Boon for Kit Market
2.2.3 Physician Office Labs – A New Frontier
2.2.4 Rapid and POCT to Threaten Instrument Marke
2.2.5 OTC and DTC – Huge Market Potential
2.3 Industry Structure
2.3.1 Hospital’s Testing Share
2.3.2 Economies of Scale.  Going Away?
2.3.3 Lower Barriers to Entry for Instruments/Analyz
2.3.4 Miniturization and Technology Drive Acquisiti
2.4 Profiles of Key Companies
2.4.1 Abbott Diagnostics
2.4.2 Abcam
2.4.3 Alere (now Abbott)
2.4.4 Arlington Scientific
2.4.5 Awareness Technology
2.4.6 Beckman Coulter, Inc
2.4.7 Becton Dickinson
2.4.8 BioCartis
2.4.9 bioMerieux
2.4.10 Bioneer
2.4.11 Bio-Rad Laboratories
2.4.12 Biotek
2.4.13 Boditech Med, Inc
2.4.14 Boster Biological Technology
2.4.15 Diamedix (Erba Diagnostics)
2.4.16 Diasorin S.p.A.
2.4.17 Dynex Technologies
2.4.18 Fujirebio
2.4.19 GE Healthcare
2.4.20 Gold Standard Diagnostics
2.4.21 Grifols
2.4.22 Hycor Biomedical
2.4.23 Immunodiagnostic Systems (IDS)
2.4.24 Immunodiagnostik AG
2.4.25 Inova Diagnostics
2.4.26 JR Biomedical
2.4.27 Luminex Corp
2.4.28 Meso Scale Discovery
2.4.29 Molecular Devices
2.4.30 MP Biomedical
2.4.31 MyCartis
2.4.32 Ortho Clinical Diagnostics
2.4.33 PerkinElmer
2.4.34 Qiagen
2.4.35 Randox Toxicology
2.4.36 R&D Systems
2.4.37 Roche Molecular Diagnostics
2.4.38 Serametrix
2.4.39  Siemens Healthineers
2.4.40 Sigma Aldrich
2.4.41 Tecan
2.4.42 Thermo Fisher Scientific Inc.
2.4.43 TOSOH Bioscience
2.4.44 Wako Diagnostics.

3. Market Trends
3.1 Factors Driving Growth
3.1.1 Diagnostic Factors
3.1.2 Changing Technologies Spur Early Instrument Retirement
3.1.3 Consumer Channels Open Wider
3.1.4 Fertility Technology Comes of Age
3.2 Factors Limiting Growth
3.2.1 Increased Competition Lowers Price
3.2.2 Lower Costs
3.2.3 Lower Barriers to Entry
3.2.4 Wellness has a downside
3.3 Immunoassay Instrumentation
3.3.1 Instrumentation Tenacity
3.3.2 Declining Cost of Instruments Changes Industry Structure
3.3.3 LISTING of CURRENT INSTRUMENT SPECIFICATIONS
3.3.4 Immunoassay – CRISPR Diagnostics

4. Immunoassay Recent Developments
4.1 Recent Developments – Importance and How to Use This Section
4.1.1 Importance of These Developments
4.1.2 How to Use This Section
4.2 Russian Researchers Develop Rapid Test for Heart Attack
4.3 Quidel Full-Year 2017 Revenues Spike on Triage Acquisition
4.4 Bruker Announces Acquisition of Field-Portable Platform
4.5 Beckman Coulter Goes to Court to Sell its BNP Assay
4.6 DiaSorin to buy Siemens' ELISA Immunodiagnostics Business .
4.7 Qiagen will acquire Spanish biotech STAT-Dx for up to €153M
4.8 Erba Dx Acquires Calbiotech
4.9 Quidel Closes $14M Acquisition of POC Eye Health Businesses
4.10 Precision for Medicine Buys Immune Monitoring Lab Epiontis
4.11 Immunalysis Receives FDA Clearance for SEFRIA™ Fentanyl Urine Drug Screening Test
4.12 Tecan acquires IBL International for specialty diagnostics
4.13 Zimmer buys CD Diagnostics to gain musculoskeletal Dx
4.14 Abcam, Molecular Devices join forces to develop immunoassays
4.15 Qiagen inks $191M deal to buy infection test panel firm STAT-Dx
4.16 Roche pens septic shock diagnostic pact
4.17  Mologic grabs CE mark for POC vaginosis test
4.18  Over-the-counter HIV test earns CE mark
4.19 Beckman Coulter Diagnostics receives FDA clearance for AMH Immunoassay to benefit fertility patients
4.20 Abbott Announces FDA Clearance for its Alinity™ ci-series Next-generation Diagnostic Systems
4.21 Gold Standard Assay Techniques vs. Multiplex
4.22 Beckman Coulter Diagnostics - Enhancements of Access 2 Immunoassay System
4.23  New handheld spectral analyzer uses power of smartphone to detect disease
4.24  Quanterix to Launch High-Sensitivity Benchtop Multiplex Instrument

5.Country Markets – North America
5.1 United States of America
5.1.1 United States Market – Overview and Discussion
5.1.2 Revenues by Instrument Type
5.1.3 Revenues by Application
5.2 Canada
5.2.1 Canada Market – Overview and Discussion
5.2.2 Revenues by Instrument Type
5.2.3 Revenues by Application

6. Country Markets – Europe
6.1 France
6.1.1 France Market – Overview and Discussion
6.1.2 Revenues by Instrument Type
6.1.3 Revenues by Application
6.2 Germany
6.2.1 Germany Market – Overview and Discussion
6.2.2 Revenues by Instrument Type
6.2.3 Revenues by Application
6.3 United Kingdom
6.3.1 UK Market – Overview and Discussion
6.3.2 Revenues by Instrument Type
6.3.3 Revenues by Application
6.4 Spain
6.4.1 Spain Market – Overview and Discussion
6.4.2 Revenues by Instrument Type
6.4.3 Revenues by Application
6.5 Italy
6.5.1 Italy Market – Overview and Discussion
6.5.2 Revenues by Instrument Type
6.5.3 Revenues by Application
6.6 Russia
6.6.1 Russia Market – Overview and Discussion
6.6.2 Revenues by Instrument Type
6.6.3 Revenues by Application
6.7 Remainder of Europe and Former Soviet Union
6.7.1 RoE Market – Overview and Discussion
6.7.2 Revenues by Instrument Type
6.7.3 Revenues by Application

7. Country Markets – Asia Pacific
7.1 China
7.1.1 China Market – Overview and Discussion
7.1.2 Revenues by Instrument Type
7.1.3 Revenues by Application
7.2 Japan
7.2.1 Japan Market – Overview and Discussion
7.2.2 Revenues by Instrument Type
7.2.3 Revenues by Application
7.3 South Korea
7.3.1 South Korea Market – Overview and Discussion
7.3.2 Revenues by Instrument Type
7.3.3 Revenues by Application
7.4 India
7.4.1 India Market – Overview and Discussion
7.4.2 Revenues by Instrument Type
7.4.3 Revenues by Application
7.5 Australia
7.5.1 Australia Market – Overview and Discussion
7.5.2 Revenues by Instrument Type
7.5.3 Revenues by Application
7.6 Rest of Asia Pacific
7.6.1 RoAP Market – Overview and Discussion
7.6.2 Revenues by Instrument Type
7.6.3 Revenues by Application

8. Country Markets – Latin America, Africa & The Middle East
8.1 Brazil
8.1.1 Brazil Market – Overview and Discussion
8.1.2 Revenues by Instrument Type
8.1.3 Revenues by Application
8.2 Mexico
8.2.1 Brazil Market – Overview and Discussion
8.2.2 Revenues by Instrument Type
8.2.3 Revenues by Application
8.3 Rest of Latin America
8.3.1 RoLA Market – Overview and Discussion
8.3.2 Revenues by Instrument Type
8.3.3 Revenues by Application
8.4 Africa & The Middle East
8.4.1 Africa & The Middle East Market – Overview and Discussion
8.4.2 Revenues by Instrument Type
8.4.3 Revenues by Application

9. Global Market Summary
9.1 Global Market
9.1.1 Global Market – Overview and Discussion
9.1.2 Revenues by Instrument Type
9.1.3 Revenues by Application
10. Vision of the Future of Immunoassay

Appendices
I. United States Medicare System: January 2018 laboratory Fees Schedule – National Limit and Midpoint
II Methodology
II.1 Authors
II.2 Sources

List of Tables
Table 1  The Base Pairs
Table 2 Medicare Clinical Lab Expenditures Actual & Forecast 2004 to 2020 ($Billion)
Table 3  Market Players by Type
Table 4 The Different Markets for Immunoassay
Table 5 The Factors Driving Growth
Table 6 Factors Limiting Growth
Table 7 - Listing of Current Instrument Specifications
Table 8 USA Instrument Revenues
Table 9 USA Immunoassay Market by Application
Table 10 Canada Instrument Revenues
Table 11 Canada Immunoassay Market by Application
Table 12 France Instrument Revenues
Table 13 France Immunoassay Market by Application
Table 14 Germany Instrument Revenues
Table 15 Germany Immunoassay Market by Application
Table 16 UK Instrument Revenues
Table 17 UK Immunoassay Market by Application
Table 18 Spain Instrument Revenues
Table 19 Spain Immunoassay Market by Application
Table 20 Italy Instrument Revenues
Table 21 Italy Immunoassay Market by Application
Table 22 Russia Instrument Revenues
Table 23 Russia Immunoassay Market by Application
Table 24 RoE Instrument Revenues
Table 25 RoE Immunoassay Market by Application
Table 26 China Instrument Revenues
Table 27 China Immunoassay Market by Application
Table 28 Japan Instrument Revenues
Table 29 Japan Immunoassay Market by Application
Table 30 S Korea Instrument Revenues
Table 31 S Korea Immunoassay Market by Application
Table 32 India Instrument Revenues
Table 33 Ind Imiamunoassay Market by Application
Table 34 Australia Instrument Revenues
Table 35 Australia Immunoassay Market by Application
Table 36 RoAP Instrument Revenues
Table 37 RoAP Immunoassay Market by Application
Table 38 Brazil Instrument Revenues
Table 39 Brazil Immunoassay Market by Application
Table 40 Mexico Instrument Revenues
Table 41 Mexico Immunoassay Market by Application
Table 42 RoLA Instrument Revenues
Table 43 RoLA Immunoassay Market by Application
Table 44 AME Instrument Revenues
Table 45 AME Immunoassay Market by Application
Table 46 Global Instrument Revenues
Table 47 Global Immunoassay Market by Application
Table 48 2018 Clinical Lab Fee Schedule

Table of Figures
Figure 1 Medicare Clinical Lab Expenditures 2004 to 2020 ($Million)

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Abbott Diagnostics
  • Abcam
  • Arlington Scientific
  • Awareness Technology
  • Beckman Coulter, Inc
  • Becton Dickinson
  • Bio-Rad Laboratories
  • BioCartis
  • bioMerieux
  • Bioneer
  • Biotek
  • Boditech Med, Inc
  • Boster Biological Technology
  • Diamedix (Erba Diagnostics)
  • Diasorin S.p.A.
  • Dynex Technologies
  • Fujirebio
  • GE Healthcare
  • Gold Standard Diagnostics
  • Grifols
  • Hycor Biomedical
  • Immunodiagnostic Systems (IDS)
  • Immunodiagnostik AG
  • Inova Diagnostics
  • JR Biomedical
  • Luminex Corp
  • Meso Scale Discovery
  • Molecular Devices
  • MP Biomedical
  • MyCartis
  • Ortho Clinical Diagnostics
  • PerkinElmer
  • Qiagen
  • R&D Systems
  • Randox Toxicology
  • Roche Molecular Diagnostics
  • Serametrix
  • Siemens Healthineers
  • Sigma Aldrich
  • Tecan
  • Thermo Fisher Scientific Inc.
  • TOSOH Bioscience
  • Wako Diagnostics
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll